drugset / Trial / NCT00912054
DuoTrav APS Versus XALACOM® in Ocular Surface Health
RandomizedParallel-groupDouble-blindTreatment
Summary
To demonstrate superiority of DuoTrav APS over XALACOM® in Ocular Surface Health in patients with open angle glaucoma or ocular hypertension.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Latanoprost | Small molecule | 50 ug/ml | Other |
| Subject | Travoprost | Other / unclassified | 40 ug/ml | Other |
| Background | Timolol | Other / unclassified | 5 mg/ml | Other |